Literature DB >> 23348894

Acute but transient release of terminal complement complex after reperfusion in clinical kidney transplantation.

Dorottya K de Vries1, Pieter van der Pol, Gerritje E van Anken, Danielle J van Gijlswijk, Jeffrey Damman, Jan H Lindeman, Marlies E J Reinders, Alexander F Schaapherder, Cees van Kooten.   

Abstract

BACKGROUND: Ischemia/reperfusion (I/R) injury has a major impact on kidney graft function and survival. Animal studies have suggested a role for complement activation in mediating I/R injury; however, results are not unambiguous. Whether complement activation is involved in clinical I/R injury in humans is still unclear.
METHODS: In the present study, we assessed the formation and release of C5b-9 during early reperfusion in clinical kidney transplantation in living donor, brain-dead donor, and cardiac dead donor kidney transplantation. By arteriovenous measurements and histologic studies, local terminal complement activation in the reperfused kidney was assessed.
RESULTS: There was no release of soluble C5b-9 (sC5b-9) from living donor kidneys, nor was there a release of C5a. In contrast, instantly after reperfusion, there was a significant but transient venous release of sC5b-9 from the reperfused kidney graft in brain-dead donor and cardiac dead donor kidney transplantation. This short-term activation of the terminal complement cascade in deceased-donor kidney transplantation was not reflected by renal tissue deposition of C5b-9 in biopsies taken 45 min after reperfusion.
CONCLUSIONS: This systematic study in human kidney transplantation shows an acute but nonsustained sC5b-9 release on reperfusion in deceased-donor kidney transplantation. This instantaneous, intravascular terminal complement activation may be induced by intravascular cellular debris and hypoxic or injured endothelium.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23348894     DOI: 10.1097/TP.0b013e31827e31c9

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  24 in total

Review 1.  Molecules Great and Small: The Complement System.

Authors:  Douglas R Mathern; Peter S Heeger
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-07       Impact factor: 8.237

2.  Targeted donor complement blockade after brain death prevents delayed graft function in a nonhuman primate model of kidney transplantation.

Authors:  Juan S Danobeitia; Tiffany J Zens; Peter J Chlebeck; Laura J Zitur; Jose A Reyes; Michael J Eerhart; Jennifer Coonen; Saverio Capuano; Anthony M D'Alessandro; Jose R Torrealba; Daniel Burguete; Kevin Brunner; Edwin Van Amersfoort; Yolanda Ponstein; Cees Van Kooten; Ewa Jankowska-Gan; William Burlingham; Jeremy Sullivan; Arjang Djamali; Myron Pozniak; Yucel Yankol; Luis A Fernandez
Journal:  Am J Transplant       Date:  2020-02-20       Impact factor: 8.086

Review 3.  Complement as a multifaceted modulator of kidney transplant injury.

Authors:  Paolo Cravedi; Peter S Heeger
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

Review 4.  Complement cascade and kidney transplantation: The rediscovery of an ancient enemy.

Authors:  Alberto Mella; Maria Messina; Antonio Lavacca; Luigi Biancone
Journal:  World J Transplant       Date:  2014-09-24

5.  Complement Inhibitor CRIg/FH Ameliorates Renal Ischemia Reperfusion Injury via Activation of PI3K/AKT Signaling.

Authors:  Chao Hu; Long Li; Peipei Ding; Ling Li; Xiaowen Ge; Long Zheng; Xuanchuan Wang; Jina Wang; Weitao Zhang; Na Wang; Hongyu Gu; Fan Zhong; Ming Xu; Ruiming Rong; Tongyu Zhu; Weiguo Hu
Journal:  J Immunol       Date:  2018-11-14       Impact factor: 5.422

6.  Donor Urinary C5a Levels Independently Correlate With Posttransplant Delayed Graft Function.

Authors:  Bernd Schröppel; Peter S Heeger; Heather Thiessen-Philbrook; Isaac E Hall; Mona D Doshi; Francis L Weng; Peter P Reese; Chirag R Parikh
Journal:  Transplantation       Date:  2019-01       Impact factor: 4.939

7.  Acute kidney injuries induced by thrombotic microangiopathy following severe hemorrhage in puerperants: a case series and literature review.

Authors:  Xu Wang; Chun-Yan Liu; Yue Yang; Gu-Ming Zou; Li Zhuo; Su-Hui Han; Wen-Ge Li
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

8.  C3 glomerulonephritis secondary to mutations in factors H and I: rapid recurrence in deceased donor kidney transplant effectively treated with eculizumab.

Authors:  Neetika Garg; Yuzhou Zhang; Anne Nicholson-Weller; Eliyahu V Khankin; Nicolò Ghiringhelli Borsa; Nicole C Meyer; Susan McDermott; Isaac E Stillman; Helmut G Rennke; Richard J Smith; Martha Pavlakis
Journal:  Nephrol Dial Transplant       Date:  2018-12-01       Impact factor: 5.992

9.  No indications for platelet activation in acute clinical myocardial or renal ischemia/reperfusion injury.

Authors:  Kirsten A Kortekaas; Dorottya K de Vries; Mark Roest; Marlies Ej Reinders; Eric P van der Veer; Robert Jm Klautz; Philip G de Groot; Alexander F Schaapherder; Jan H Lindeman
Journal:  Am J Transl Res       Date:  2018-03-15       Impact factor: 4.060

10.  Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation.

Authors:  Ha Tran; Abanti Chaudhuri; Waldo Concepcion; Paul C Grimm
Journal:  Pediatr Nephrol       Date:  2013-11-13       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.